| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.28 | 6e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-06 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0005 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0008 |